Detalles de la búsqueda
1.
Current Place of SGLT2i in the Management of Heart Failure: An Expert Opinion from India.
J Assoc Physicians India
; 72(1): 63-73, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736076
2.
The Promise of Cilnidipine in Hypertension with Comorbidities: National Consensus Statement: National Consensus Group Comprises Cardiologists, Nephrologists, and Diabetologists from India in a National Meet at New Delhi held on 22nd May 2022.
J Assoc Physicians India
; 72(1): 88-95, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736080
3.
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.
J Assoc Physicians India
; 72(5): 77-88, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38881115
4.
Role of Iron Therapy in Heart Failure: A Consensus Statement from India.
J Assoc Physicians India
; 71(3): 11-12, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354511
5.
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from India.
J Assoc Physicians India
; 71(4): 11-12, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355795
6.
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement.
J Assoc Physicians India
; 71(2): 11-12, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37354473
7.
Role of Bisoprolol in Heart Failure Management: A Consensus Statement from India.
J Assoc Physicians India
; 71(12): 77-88, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736057
8.
9.
Resultados
1 -
9
de 9
1
Próxima >
>>